Foundation to fund up to $110 million for collaboration to accelerate the development of genetic therapies for CF
Today, the Cystic Fibrosis Foundation announced that it has awarded up to $400,000 to Life Edit Therapeutics Inc. to explore the application of their unique gene editing technology in CF.
|
3 min read
New funding will support clinical development of two novel therapies to address complications of cystic fibrosis
|
3 min read
The Cystic Fibrosis Lung Transplant Consortium Biorepository and Patient Registry, in collaboration with Cleveland Clinic, will provide critical clinical data and samples to support future research investigating complications of lung transplant.
|
4 min read